ds 4574 has been researched along with cromolyn sodium in 1 studies
Studies (ds 4574) | Trials (ds 4574) | Recent Studies (post-2010) (ds 4574) | Studies (cromolyn sodium) | Trials (cromolyn sodium) | Recent Studies (post-2010) (cromolyn sodium) |
---|---|---|---|---|---|
13 | 2 | 0 | 4,204 | 898 | 246 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furuhama, K; Kawarabayashi, K; Tabuchi, Y | 1 |
1 other study(ies) available for ds 4574 and cromolyn sodium
Article | Year |
---|---|
Inhibitory effect of DS-4574, a peptidoleukotriene antagonist with mast cell stabilizing action, on compound 48/80-induced gastric mucosal lesions in rats.
Topics: Acetophenones; Administration, Oral; Animals; Cimetidine; Cromolyn Sodium; Gastric Mucosa; Histamine; Histamine Release; Injections, Intraperitoneal; Injections, Subcutaneous; Leukotriene Antagonists; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Pyrimidines; Rats; Rats, Sprague-Dawley; Tetrazoles; Triazoles | 1994 |